RGLS REGULUS THERAPEUTICS INC Management Changes 8-K Filing 2023 - Annual Meeting and Amendments to Equity Incentive Plan Regulus Therapeutics Inc. held its 2023 Annual Meeting of Stockholders on June 13, 2023, where the stockholders approved an amendment to the company's 2019 Equity Incentive Plan and elected directors. They also approved the compensation of named executive officers and ratified the selection of Ernst & Young LLP as the independent registered public accounting firm.Get access to all SEC 8-K filings of the REGULUS THERAPEUTICS INC